Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/25/19 → 11/25/24 |
Funding
- Exelixis Inc. (Prot #NU 19S01)
Prot #NU 19S01: A Phase II Study of Cabozantinib and Temozolomide in Patients with Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
- Mulcahy, Mary Frances (PD/PI)
Project: Research project